[
  {
    "ts": "2025-11-20T12:25:06+00:00",
    "headline": "Regeneron’s Eylea franchise boosted by pair of FDA approvals",
    "summary": "Eylea HD’s new RVO indication and a monthly dosing option will notch up the rivalry with Roche’s Vabysmo.",
    "url": "https://www.pharmaceutical-technology.com/news/regenerons-eylea-franchise-boosted-by-pair-of-fda-approvals/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "02f108e4-8404-3b3f-a25f-5a1a382070db",
      "content": {
        "id": "02f108e4-8404-3b3f-a25f-5a1a382070db",
        "contentType": "STORY",
        "title": "Regeneron’s Eylea franchise boosted by pair of FDA approvals",
        "description": "",
        "summary": "Eylea HD’s new RVO indication and a monthly dosing option will notch up the rivalry with Roche’s Vabysmo.",
        "pubDate": "2025-11-20T12:25:06Z",
        "displayTime": "2025-11-20T12:25:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/c3f05e07237ca9c369702d71e007f3bf",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G62QEtIF546bCWwYWypliw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/c3f05e07237ca9c369702d71e007f3bf.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s.nQ_ljtJuO6NZl17KGshQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/c3f05e07237ca9c369702d71e007f3bf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/regenerons-eylea-franchise-boosted-by-pair-of-fda-approvals/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-eylea-franchise-boosted-pair-122506595.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            },
            {
              "symbol": "ROG.SW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-20T15:34:13+00:00",
    "headline": "Stocks to Watch Thursday: Walmart, Nvidia, Exact Sciences, Regeneron",
    "summary": "↗️ Walmart (WMT): The biggest U.S. retailer and private-sector employer posted solid quarterly results and raised its outlook. Shares climbed 6%. ↗️ Nvidia (NVDA): The chip maker reported record sales and issued strong guidance, helping ease angst about an artificial-intelligence bubble.",
    "url": "https://www.wsj.com/livecoverage/jobs-report-bls-september-stock-market-today-11-20-2025/card/stocks-to-watch-thursday-nvidia-amd-walmart-6oQvCREXi20dufYs21ry?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "c12dd2a4-ebaa-3cb1-a576-7aea5d2a6219",
      "content": {
        "id": "c12dd2a4-ebaa-3cb1-a576-7aea5d2a6219",
        "contentType": "STORY",
        "title": "Stocks to Watch Thursday: Walmart, Nvidia, Exact Sciences, Regeneron",
        "description": "",
        "summary": "↗️ Walmart (WMT): The biggest U.S. retailer and private-sector employer posted solid quarterly results and raised its outlook. Shares climbed 6%. ↗️ Nvidia (NVDA): The chip maker reported record sales and issued strong guidance, helping ease angst about an artificial-intelligence bubble.",
        "pubDate": "2025-11-20T15:34:13Z",
        "displayTime": "2025-11-20T15:34:13Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/c12dd2a4-ebaa-3cb1-a576-7aea5d2a6219/stocks-to-watch-thursday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/2fe33970c8bdf092fb792f6e87e5802b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M7_rA.nIZVw1Y9F9FSCaKw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/2fe33970c8bdf092fb792f6e87e5802b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jRFdkZ8IsIDLovdMAGDDFw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/2fe33970c8bdf092fb792f6e87e5802b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/jobs-report-bls-september-stock-market-today-11-20-2025/card/stocks-to-watch-thursday-nvidia-amd-walmart-6oQvCREXi20dufYs21ry?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WMT"
            },
            {
              "symbol": "BBWI"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "EXAS"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-20T14:19:00+00:00",
    "headline": "REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD",
    "summary": "Regeneron gains EC approval to expand Libtayo's use in high-risk CSCC. The FDA approves Eylea HD the treatment of patients with macular edema following retinal vein occlusion.",
    "url": "https://finance.yahoo.com/news/regn-gets-ec-nod-libtayo-141900472.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "afa6dcd5-23c3-38f1-887c-157e6904f2df",
      "content": {
        "id": "afa6dcd5-23c3-38f1-887c-157e6904f2df",
        "contentType": "STORY",
        "title": "REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD",
        "description": "",
        "summary": "Regeneron gains EC approval to expand Libtayo's use in high-risk CSCC. The FDA approves Eylea HD the treatment of patients with macular edema following retinal vein occlusion.",
        "pubDate": "2025-11-20T14:19:00Z",
        "displayTime": "2025-11-20T14:19:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/57.Lfvcoa8N_9pHFAUTShA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/39hBnd4FwGlouiqapgQKxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regn-gets-ec-nod-libtayo-141900472.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regn-gets-ec-nod-libtayo-141900472.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "BAYZF"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-20T11:36:00+00:00",
    "headline": "With new approvals, Regeneron’s higher-dose Eylea gets more competitive",
    "summary": "Analysts say the two new indications should help Eylea HD as Regeneron battles for market share with Roche’s Vabysmo.",
    "url": "https://www.biopharmadive.com/news/regeneron-eylea-hd-fda-approvals-eye-market-roche/806053/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "a83ab303-47b4-3521-94bc-4cc54c2de120",
      "content": {
        "id": "a83ab303-47b4-3521-94bc-4cc54c2de120",
        "contentType": "STORY",
        "title": "With new approvals, Regeneron’s higher-dose Eylea gets more competitive",
        "description": "",
        "summary": "Analysts say the two new indications should help Eylea HD as Regeneron battles for market share with Roche’s Vabysmo.",
        "pubDate": "2025-11-20T11:36:00Z",
        "displayTime": "2025-11-20T11:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/6c457f09b31ec38cbcee1b86f4fd559e",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "FDA headquarters in White Oak, Maryland",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S1HyqXOsMPbVH30jua67bw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/6c457f09b31ec38cbcee1b86f4fd559e.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/92iy8Wi9RZeX2J..w0ijaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/6c457f09b31ec38cbcee1b86f4fd559e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/regeneron-eylea-hd-fda-approvals-eye-market-roche/806053/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/approvals-regeneron-higher-dose-eylea-113600137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-20T16:08:45+00:00",
    "headline": "Stock Market Today: Nasdaq, S&P 500 Stage Modest Comeback After Post-Earnings Nvidia Decline",
    "summary": "This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Thursday. This is TheStreet’s Stock Market Today for Nov. 20, 2025. You can follow the latest updates on the market ...",
    "url": "https://www.thestreet.com/latest-news/stock-market-today-nasdaq-sp-500-leaps-over-1-in-premarket-after-nvidias-strong-showing",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "d112f9e5-6eeb-3ff3-a196-c259217f170e",
      "content": {
        "id": "d112f9e5-6eeb-3ff3-a196-c259217f170e",
        "contentType": "STORY",
        "title": "Stock Market Today: Nasdaq, S&P 500 Stage Modest Comeback After Post-Earnings Nvidia Decline",
        "description": "",
        "summary": "This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Thursday. This is TheStreet’s Stock Market Today for Nov. 20, 2025. You can follow the latest updates on the market ...",
        "pubDate": "2025-11-20T16:08:45Z",
        "displayTime": "2025-11-20T16:08:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/4049739ae41d4f0ec6a3c8b8c9206529",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TgeJY0nMnH9YYzTRVFTqKg--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/4049739ae41d4f0ec6a3c8b8c9206529.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/15ruKsaef_wqBA1BftVZdg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/4049739ae41d4f0ec6a3c8b8c9206529.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/latest-news/stock-market-today-nasdaq-sp-500-leaps-over-1-in-premarket-after-nvidias-strong-showing",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stock-market-today-nasdaq-leaps-160845331.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "HOOD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]